MedPath

comparision of rivaroxaban with enoxaparin in fractures

Phase 3
Recruiting
Conditions
Thromboembolic events.
Pulmonary embolism
Registration Number
IRCT20190305042931N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
242
Inclusion Criteria

All individuals aged 18 to 70 years with major lower limb fractures undergoing skeletal fixation surgery will be included in this study.

Exclusion Criteria

History of thromboembolic events
History of major hemorrhages without cause
Women who take OCP
Several fractures in the lower extremities or simultaneous fractures in the upper extremity
consciousness level disturbance
Joint patient with other surgical services

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of thromboembolic events in patient. Timepoint: Up to 3 months after trauma. Method of measurement: Lower limbs Color Doppler Ultrasound.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath